JWH 133 (in Tocrisolve™ 100)

Name JWH 133 (in Tocrisolve™ 100)
Supplier Tocris Bioscience
Catalog 1343
Prices $149.00, $629.00
Sizes 5 mg, 25 mg
Function Type Agonist
Cas Number 259869-55-1
Chemical Name (6aR,10aR)-3-(1,1-dimethylbutyl)-6a,7,10,10a-tetrahydro-6,6,9-trimethyl-6H-dibenzo[b,d]pyran
Formula C22H32O
Molecular Weight 312.49
Description Potent CB 2 selective agonist (K i = 3.4 nM), in water-soluble emulsion (for details see Tocrisolve TM 100 Cat. No. 1684). Approx. 200-fold selective over CB 1 receptors. Active in vivo , reducing spasticity in a murine model of multiple sclerosis. JWH 133 also available as a solid (Cat. No. 1343).
Supplier Page Shop

Product References

3-(1',1'-Dimethylbutyl)-1-deoxy-delta8-THC and related compounds: synthesis of - 3-(1',1'-Dimethylbutyl)-1-deoxy-delta8-THC and related compounds: synthesis of

Huffman JW, Liddle J, Yu S, Aung MM, Abood ME, Wiley JL, Martin BR. Bioorg Med Chem. 1999 Dec;7(12):2905-14.

Pharmacology of cannabinoid receptor ligands. - Pharmacology of cannabinoid receptor ligands.

Pertwee RG. Curr Med Chem. 1999 Aug;6(8):635-64.

Cannabinoids control spasticity and tremor in a multiple sclerosis model. - Cannabinoids control spasticity and tremor in a multiple sclerosis model.

Baker D, Pryce G, Croxford JL, Brown P, Pertwee RG, Huffman JW, Layward L. Nature. 2000 Mar 2;404(6773):84-7.